|
|
|
March 7, 2000
The Honorable Dan K. Morhaim
Maryland House of Delegates
304 Lowe House Office Building
Annapolis, Maryland 21401-1991
Re: HB 257, Nongerminating Genetically Engineered Seed -
Prohibition
Dear Delegate Morhaim:
Thank you for asking Consumers Union to comment on HB 257,
Nongerminating Genetically Engineered Seed - Prohibition, which would
prohibit the sale, distribution, or use of certain nongerminating
genetically engineered seed in Maryland. I am sorry that we are
unable to deliver these comments in person at the Environmental
Matters Committee hearing on this legislation.
Consumers Union, publisher of Consumer Reports magazine, is
an independent, nonprofit organization dedicated to testing,
educational programs, and information services to benefit consumers.
We are a comprehensive source of unbiased advice about products and
services, personal finance, health, nutrition and other consumer
concerns. Since 1936, our mission has been to test products, inform
the public and protect consumers.
Genetic seed sterilization technology - more commonly known as
"terminator technology" - raises grave concerns for farmers, the
environment, and ultimately all consumers.
Saving seed for planting in subsequent growing seasons has been an
agricultural tradition for thousands of years. Many American farmers
rely on this practice to make their operations profitable enough to
continue farming year after year. In the third world, saving seed is
absolutely essential for the survival of millions of people. Wide
dissemination of gene sterilization technology would place a huge
economic burden on these farmers, their families and the communities
they serve. Moreover, there is no guarantee that use of these
genetically altered seeds will increase yields (or commodity prices)
sufficiently to make up for the additional cost of buying these seeds
on an annual basis. Indeed, many farmers are now forced to sell
their genetically modified crops, which do not yet contain
sterilization genes, at a discount.
In addition, requiring farmers to purchase seed on an annual basis
would dramatically shift the balance of power within the agricultural
production system from the farmer to large agrochemical companies
that have the economic clout to dictate farming practices on a global
scale. Given the recent, and continuing, consolidation of
agricultural seed production, this raises serious antitrust concerns.
More importantly, it raises questions about global food security.
Multi-national corporations would be in a position to make binding
decisions about who will have access to seed, and therefore who will
not, and all of the genetically altered traits the seed will carry.
All of this would be on terms most favorable to the seed company.
This concentration of power obviously has potentially dangerous
implications for farming, consumers, and the global economy.
Also of great concern is the impossibility of containing this
technology once it is introduced into the environment. No use of
technology can ensure that the sterilization gene will not be
transferred to other crops that were not engineered to carry this
trait. This could have adverse consequences for farmers who have
chosen to avoid genetically engineered crops simply because they are
downwind of a field planted with gene sterilized crops. This raises
liability questions, as well as concerns about future output from
farms that are inadvertently contaminated. In addition, technology
cannot prevent the transfer of the sterilization gene to wild plant
species, the consequences of which are impossible to gauge.
Ultimately, the increased costs that farmers may have to bear
because of gene sterilization technology would be passed on to
consumers in the form of higher grocery bills. Use of the technology
could reduce consumer choice as well. These concerns would become
more acute as seed production is consolidated within fewer and fewer
multi-national corporations with the power to dictate what ends up on
the shelf. The only ones who seem to benefit from the introduction
of gene sterilization technology would be the agrochemical companies
that produce the seeds.
For these reasons, we oppose the development, sale or use of gene
sterilization technologies, and therefore support HB 257. We urge
its favorable consideration by the Environmental Matters Committee
and the Maryland General Assembly.
Thank you again for asking us to comment on this legislation.
Sincerely,
Adam J. Goldberg
Policy Analyst
Washington, DC Office
